NeuroMetrix, Inc.
NURO
$4.42
$0.07771.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.03M | 3.77M | 4.38M | 5.27M | 5.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.03M | 3.77M | 4.38M | 5.27M | 5.90M |
| Cost of Revenue | 1.32M | 1.57M | 1.71M | 1.97M | 1.95M |
| Gross Profit | 1.71M | 2.20M | 2.67M | 3.30M | 3.95M |
| SG&A Expenses | 8.56M | 8.49M | 8.89M | 8.82M | 8.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.23M | 11.87M | 12.70M | 13.39M | 13.05M |
| Operating Income | -8.20M | -8.10M | -8.32M | -8.12M | -7.15M |
| Income Before Tax | -7.81M | -7.68M | -7.94M | -7.98M | -6.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.81 | -7.68 | -7.94 | -7.98 | -6.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.81M | -7.68M | -7.94M | -7.98M | -6.53M |
| EBIT | -8.20M | -8.10M | -8.32M | -8.12M | -7.15M |
| EBITDA | -8.11M | -8.00M | -8.24M | -8.04M | -7.10M |
| EPS Basic | -4.03 | -4.59 | -5.51 | -6.32 | -6.29 |
| Normalized Basic EPS | -2.54 | -2.95 | -3.55 | -3.96 | -4.14 |
| EPS Diluted | -4.03 | -4.59 | -5.51 | -6.32 | -6.29 |
| Normalized Diluted EPS | -2.54 | -2.95 | -3.55 | -3.96 | -4.14 |
| Average Basic Shares Outstanding | 7.88M | 6.99M | 6.03M | 5.02M | 4.17M |
| Average Diluted Shares Outstanding | 7.88M | 6.99M | 6.03M | 5.02M | 4.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |